TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study.

Huiqiang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.